Second-line irinotecan after cisplatin, fluoropyrimidin and docetaxel for chemotherapy of metastatic gastric cancer

dc.contributor.authors	Kucukzeybek Y, Dirican A, Erten C, Somali I, Can A, Demir L, Bayoglu IV, Akyol M, Medeni M, Tarhan MO
dc.date.accessioned	2020-02-27T08:35:14Z
dc.date.available	2020-02-27T08:35:14Z
dc.date.issued	2012
dc.identifier.citation	Kucukzeybek Y, Dirican A, Erten C, Somali I, Can A, Demir L, Bayoglu IV, Akyol M, Medeni M, Tarhan MO (2012). Second-line irinotecan after cisplatin, fluoropyrimidin and docetaxel for chemotherapy of metastatic gastric cancer. Asian Pac J Cancer Prev, 13(6), 4-2771
dc.identifier.uri	https://hdl.handle.net/20.500.12619/66480
dc.title	Second-line irinotecan after cisplatin, fluoropyrimidin and docetaxel for chemotherapy of metastatic gastric cancer
dc.identifier.volume	13(6)
dc.identifier.startpage	2771
dc.identifier.endpage	4
dc.contributor.department	Sakarya Üniversitesi/Tıp Fakültesi/Dahili Tıp Bilimleri Bölümü
dc.contributor.saüauthor	Bayoğlu, İbrahim Vedat
dc.relation.journal	Asian Pac J Cancer Prev
dc.contributor.author	Bayoğlu, İbrahim Vedat